Correlation Between Quoin Pharmaceuticals and Bio Path

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Quoin Pharmaceuticals and Bio Path at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Quoin Pharmaceuticals and Bio Path into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Quoin Pharmaceuticals Ltd and Bio Path Holdings, you can compare the effects of market volatilities on Quoin Pharmaceuticals and Bio Path and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Quoin Pharmaceuticals with a short position of Bio Path. Check out your portfolio center. Please also check ongoing floating volatility patterns of Quoin Pharmaceuticals and Bio Path.

Diversification Opportunities for Quoin Pharmaceuticals and Bio Path

-0.11
  Correlation Coefficient

Good diversification

The 3 months correlation between Quoin and Bio is -0.11. Overlapping area represents the amount of risk that can be diversified away by holding Quoin Pharmaceuticals Ltd and Bio Path Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bio Path Holdings and Quoin Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Quoin Pharmaceuticals Ltd are associated (or correlated) with Bio Path. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bio Path Holdings has no effect on the direction of Quoin Pharmaceuticals i.e., Quoin Pharmaceuticals and Bio Path go up and down completely randomly.

Pair Corralation between Quoin Pharmaceuticals and Bio Path

Given the investment horizon of 90 days Quoin Pharmaceuticals Ltd is expected to generate 1.27 times more return on investment than Bio Path. However, Quoin Pharmaceuticals is 1.27 times more volatile than Bio Path Holdings. It trades about 0.17 of its potential returns per unit of risk. Bio Path Holdings is currently generating about -0.15 per unit of risk. If you would invest  62.00  in Quoin Pharmaceuticals Ltd on September 13, 2024 and sell it today you would earn a total of  15.00  from holding Quoin Pharmaceuticals Ltd or generate 24.19% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Quoin Pharmaceuticals Ltd  vs.  Bio Path Holdings

 Performance 
       Timeline  
Quoin Pharmaceuticals 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Quoin Pharmaceuticals Ltd are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, Quoin Pharmaceuticals showed solid returns over the last few months and may actually be approaching a breakup point.
Bio Path Holdings 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Bio Path Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unfluctuating performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in January 2025. The recent confusion may also be a sign of long-lasting up-swing for the firm traders.

Quoin Pharmaceuticals and Bio Path Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Quoin Pharmaceuticals and Bio Path

The main advantage of trading using opposite Quoin Pharmaceuticals and Bio Path positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Quoin Pharmaceuticals position performs unexpectedly, Bio Path can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bio Path will offset losses from the drop in Bio Path's long position.
The idea behind Quoin Pharmaceuticals Ltd and Bio Path Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.

Other Complementary Tools

Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios